Eurofins Scient (OTCMKTS:ERFSF – Get Free Report)’s stock price reached a new 52-week high on Wednesday. The stock traded as high as $99.7980 and last traded at $99.7980, with a volume of 312 shares trading hands. The stock had previously closed at $98.2720.
Analysts Set New Price Targets
Separately, Sanford C. Bernstein cut shares of Eurofins Scient from an “outperform” rating to a “hold” rating in a research note on Tuesday, September 29th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold”.
Read Our Latest Research Report on ERFSF
Eurofins Scient Price Performance
The business has a 50-day moving average of $88.00 and a 200-day moving average of $79.60. The company has a current ratio of 1.13, a quick ratio of 1.07 and a debt-to-equity ratio of 0.80.
Eurofins Scient Company Profile
Eurofins Scientific SE is a Luxembourg-based international laboratory and testing services company. It provides analytical, inspection and certification services for the pharmaceutical, food, environmental, agricultural, consumer products and healthcare industries.
The company’s services include laboratory testing, product safety and quality analysis, environmental monitoring, pharmaceutical development and validation, genomic testing, clinical diagnostics, and agroscience services. Eurofins also supports companies and public-sector organizations with research, regulatory compliance and quality-control programs.
Founded in 1987 by Gilles Martin, Eurofins has expanded from its original focus on food testing into a broad network of laboratories and specialized testing businesses serving customers in Europe, North America, Asia-Pacific and other international markets.
Further Reading
- Five stocks we like better than Eurofins Scient
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.
